NEXICLON XR Drug Patent Profile

✉ Email this page to a colleague

When do Nexiclon Xr patents expire, and what generic alternatives are available?

Nexiclon Xr is a drug marketed by Athena and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-one patent family members in fourteen countries.

The generic ingredient in NEXICLON XR is clonidine. There are twenty-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the clonidine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nexiclon Xr

A generic version of NEXICLON XR was approved as clonidine by DIFGEN PHARMS on August 18^th, 2009.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NEXICLON XR?
What are the global sales for NEXICLON XR?
What is Average Wholesale Price for NEXICLON XR?

Summary for NEXICLON XR

International Patents:	21
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	69
Clinical Trials:	4
Patent Applications:	6,125
What excipients (inactive ingredients) are in NEXICLON XR?	NEXICLON XR excipients list
DailyMed Link:	NEXICLON XR at DailyMed

Drug patent expirations by year for NEXICLON XR

Recent Clinical Trials for NEXICLON XR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Louisville	Phase 4
Arthroplasty Foundation, Inc.	Phase 4
Children's Hospital of Pittsburgh	N/A

See all NEXICLON XR clinical trials

Pharmacology for NEXICLON XR

Drug Class	Central alpha-2 Adrenergic Agonist
Mechanism of Action	Adrenergic alpha2-Agonists

US Patents and Regulatory Information for NEXICLON XR

NEXICLON XR is protected by two US patents.

Patents protecting NEXICLON XR

Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Clonidine formulation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Athena	NEXICLON XR	clonidine	TABLET, EXTENDED RELEASE;ORAL	022500-001	Dec 3, 2009		RX	No	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Athena	NEXICLON XR	clonidine	TABLET, EXTENDED RELEASE;ORAL	022500-002	Dec 3, 2009		DISCN	No	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Athena	NEXICLON XR	clonidine	TABLET, EXTENDED RELEASE;ORAL	022500-001	Dec 3, 2009		RX	No	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Athena	NEXICLON XR	clonidine	TABLET, EXTENDED RELEASE;ORAL	022500-002	Dec 3, 2009		DISCN	No	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for NEXICLON XR

See the table below for patents covering NEXICLON XR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
China	101400343	Modified release formulations containing drug-ion exchange resin complexes	⤷ Sign Up
Australia	2007227569	Modified release formulations containing drug-ion exchange resin complexes	⤷ Sign Up
Spain	2378573		⤷ Sign Up
Japan	2009530298		⤷ Sign Up
Russian Federation	2008140944	КОМПОЗИЦИИ С МОДИФИЦИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ КОМПЛЕКСЫ ЛЕКАРСТВЕННОЕ ВЕЩЕСТВО-ИОНООБМЕННАЯ СМОЛА	⤷ Sign Up
Taiwan	200812649	Modified release formulations containing drug-ion exchange resin complexes	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration